$QNT · Quantinuum Inc.
Quantinuum filed its Q3 FY2026 10-Q. Revenue-net rose 233.3% YoY to $9.1M for the quarter, while net loss attributable to Quantinuum Inc. was $17M ($0.46 per share). Nine-month revenue fell 7% to $22.3M, and total costs and expenses surged 399% to $787.3M, driven by $484.7M in stock compensation and a $111.8M warrant fair-value loss.
- Q3 revenue-net of $9.1M, up 233.3% YoY from $2.7M.
- Net loss attributable to Quantinuum Inc. was $17M, or.
- Nine-month revenue fell 7% to $22.3M from $23.9M.
- R&D expenses rose 130% YoY to $97.5M in Q3.
- Cash and equivalents ended at $1.94B, up from $762.6M at year-end.
Markets closed — no regular-session reaction yet; extended-hours last trade at $39.81, down 0.57% from the $40.04 close.
Quantinuum's first post-transaction quarter shows explosive revenue growth but massive R&D burn, testing whether commercialization can outpace spending.
Quantum-computing peers trade on commercialization milestones rather than near-term profitability; Quantinuum's 233% quarterly revenue growth contrasts with heavy R&D burn.
Heavy cash burn: nine-month operating loss of $765M and R&D spend of $519.4M. Reliance on Honeywell relationship and Department of Commerce award compliance are flagged as key risks.